Advanced particle accelerator technology for research and commercial applications.
Beaming with progress.
TAE’s patented particle accelerator technology is a cornerstone of the company’s unique fusion configuration. These highly flexible and tunable accelerator beams can be leveraged for commercialization in other sectors. TAE’s first subsidiary, TAE Life Sciences, has exclusively licensed this accelerator-based technology for a transformative cancer treatment, with more applications to come.
How do particle accelerators contribute to fusion and other applications?
TAE’s patented particle accelerator technology injects neutral beams to drive current, heat, and stabilize plasma for fusion. TAE Life Sciences has leveraged this innovation for a biologically targeted treatment system that selectively destroys cancer cells.